This article looks at the relationship between a CDMO quality organization and the client.
Partnerships for Outsourcing, May 2024 eBook
What do you need to ask during the vetting and selection process to ensure your clinical or commercial program won’t be derailed by a quality-related problem?
The need for preclinical testing expertise is growing as molecular complexity increases.
The rising demand for biologics and technological innovations are driving blow-fill-seal capacity, harnessing manufacturing efficiency, and benefitting patients.
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
3
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
